120 related articles for article (PubMed ID: 11020019)
1. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study.
Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R
Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019
[TBL] [Abstract][Full Text] [Related]
2. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
Zwolińska D; Szprynger K
Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
[TBL] [Abstract][Full Text] [Related]
3. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
5. [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant].
Ochoa-Sosa CA; Mondragón-Rodríguez G; Zamora-González J; Cardoso-Saldaña G; Herrera-Acosta J; Posadas-Romero C
Rev Invest Clin; 1998; 50(4):301-6. PubMed ID: 9830317
[TBL] [Abstract][Full Text] [Related]
6. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
[TBL] [Abstract][Full Text] [Related]
10. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
11. Effect of over-the-counter fish-oil administration on plasma Lp(a) levels in an end-stage renal disease population.
Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
J Ren Nutr; 2009 Nov; 19(6):443-9. PubMed ID: 19748798
[TBL] [Abstract][Full Text] [Related]
12. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.
Krane V; Krieter DH; Olschewski M; März W; Mann JF; Ritz E; Wanner C
Am J Kidney Dis; 2007 Feb; 49(2):267-75. PubMed ID: 17261429
[TBL] [Abstract][Full Text] [Related]
13. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
[TBL] [Abstract][Full Text] [Related]
14. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis.
de Gómez Dumm NT; Giammona AM; Touceda LA; Raimondi C
Medicina (B Aires); 2001; 61(2):142-6. PubMed ID: 11374135
[TBL] [Abstract][Full Text] [Related]
15. The effect of high-flux hemodialysis on renal anemia.
Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
[TBL] [Abstract][Full Text] [Related]
16. The changes in NT-proBNP plasma concentrations during dialysis are highly dependent of the dialysis membrane ultrafiltration coefficient.
Dautin G; Boudjeltia S; Soltani Z; Gambert P; Duvillard L
Clin Chim Acta; 2007 Feb; 376(1-2):237-9. PubMed ID: 16979612
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis].
Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT
Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263
[TBL] [Abstract][Full Text] [Related]
18. [Hypertension in hemodialysis patients in Andalucia].
García Cortés MJ; Ceballos M;
Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
[TBL] [Abstract][Full Text] [Related]
19. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
20. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
